Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Empire State Legalizes Recreational Marijuana
On Wednesday, March 31, 2021, New York Governor Andrew Cuomo signed S854, a bill
Mitchell
Article
Mind Over Matter: Addressing Mental Health Comorbidity With Pharmaceutical Treatment
“Mind over matter” is a familiar saying suggesting the potential of “will” to manage or overcome a physical challenge or to persevere beyond expect
Workers' Comp
Article
As prosthetic devices improve, so can injured workers’ outcomes
In the world of workers’ compensation, our responsibility is to help those who are hurt not only get back to work, but also return to the life they
Workers' Comp
Article
Examining Social Determinants of Health: The Whole Person Approach
In the past five years, terms such as advocacy, engagement, coaching, a
Workers' Comp
Virtual Event
Webinar: The Pareto Principle: Applying the 80/20 Rule to the Connected Claim in Workers’ Comp
On-Demand
Successfully managing workers’ compensation claims requires a delicate balance of connectivity, expertise, and focus.
Workers' Comp
Blog
It's time to rethink how we talk about Specialty Networks
Let’s say goodbye to the term ancillary when it comes to caregiving in workers’ compensation.